EI
KYTX icon

Ethic Inc’s Kyverna Therapeutics KYTX Stock Holding History

Ethic Inc’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Sell
11,823
-105
-0.9% -$932 ﹤0.01% 1326
2026
Q1 		$103K Sell
11,928
-681
-5% -$5.67K ﹤0.01% 1198
2025
Q4 		$119K Sell
12,609
-2,744
-18% -$20.4K ﹤0.01% 1163
2025
Q3 		$92.1K Sell
15,353
-1,683
-10% -$6.73K ﹤0.01% 1154
2025
Q2 		$55.9K Buy
+17,036
New +$42.1K ﹤0.01% 1191

Other funds holding KYTX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SIC
Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return

Ethic Inc's KYTX Position: Q2 2026 in Review

Ethic Inc reduced its Kyverna Therapeutics (KYTX) stake by 0.88% in Q2 2026, selling an estimated $932 and leaving 11,823 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

Ethic Inc first reported a position in KYTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $119K in Q4 2025. 21 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Ethic Inc held 11,823 shares of Kyverna Therapeutics worth $105K as of Q2 2026.
  • Ethic Inc sold 105 Kyverna Therapeutics shares in Q2 2026, an estimated $932.
  • Kyverna Therapeutics made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1326 holding.
  • Ethic Inc first reported a position in Kyverna Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Ethic Inc's Kyverna Therapeutics position peaked at $119K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.